by nobilistx | May 10, 2017 | Uncategorized |
We are excited to announce a partnership with Submersible Systems to create a portable inhalation device for administration of NBTX-001. Please click on the link to read our press...
by nobilistx | May 1, 2017 | Uncategorized |
Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial. Nobilis Therapeutics, Inc. announced today the completion and formal registration of an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based...